Continuous Glucose Monitoring Systems (CGMS) Market Expected to Reach $4,921 Million by 2024


quote CGMS are a more efficient monitoring and treatment alternative for patients with diabetes. Thus, FDA approval for the novel and innovative products such as artificial pancreas (dual-chambered investigational device that consists of a CGM, one insulin pump, and a control algorithm) would further drive the CGMS market. quote

Pallavi Jaiswal
Senior Analyst, Healthcare Research at AMR.

Get 20% Free Customization In This Report
Follow us on Social Media:       

According to a new report published by Allied Market Research, titled, "Continuous Glucose Monitoring Systems (CGMS) Market by Components, Demographics, and End User: Global Opportunity Analysis and Industry Forecast, 2016-2024," the market was valued at $894 million in 2016, and is projected to reach $4,921 million by 2024, registering a CAGR of 22.9% from 2018 to 2024.

Access Full Summary at : https://www.alliedmarketresearch.com/global-continuous-glucose-monitoring-systems-market

The continuous glucose monitoring systems (CGMS) market has emerged as a promising diabetes management tool for monitoring all types of diabetic patients. Replacement/repeat sales of components such as sensors drive the growth of the CGMS market. Continuous glucose monitoring systems are mainly used by patients suffering from hypo and hyperglycemic conditions. Rise in incidences of diabetes worldwide, benefits of CGMS devices over POC glucometers, increase in awareness in developing and underdeveloped economies, and technological advancements with focus on developing CGMS devices majorly drive the CGM market. However, lack of adequate reimbursement for devices is the key barrier to the adoption of the devices.

By component, sensors generated the maximum revenue, accounting for more than two-thirds share of the global continuous glucose monitoring systems market in 2016. By demographics, adult population was the highest revenue generating segment in 2016 while child population was the segment with the highest CAGR during the forecast period

Key Findings of the Continuous Glucose Monitoring Systems (CGMS) Market:

  • The sensors segment contributed for nearly two-third share of the global continuous glucose monitoring systems market in 2016.
  • The integrated insulin pumps segment is projected to grow at a significant CAGR of 17.3% from 2018 to 2023.
  • The ICUs segment is projected to grow at a significant CAGR of 22.3% during the forecast period.
  • Germany and France are the major shareholders, which collectively accounted for more than one-fourth share of the European continuous glucose monitoring systems market in 2016.
  • Japan is the major shareholder, accounting for more than one-fourth share of the Asia-Pacific continuous glucose monitoring systems market in 2016.

Geographical analysis shows, North America and Europe are the most lucrative market segments in the global CGMs market. High purchasing power that renders increased affordability for CGMS devices are the key factors responsible for the growth of this market in Europe and North America. Asia-Pacific market is expected to grow at a highest CAGR of 29.7% over the analysis period and thus constitutes potential market opportunity for the new market players. Moreover, factors such as rise in the number of patients with diabetes, growth in the purchasing power of the patients and awareness can positively impact the growth of the market in this region.

The major companies profiled in the report are Abbott Laboratories, Dexcom, Inc., A. Menarini Diagnostics, Echo Therapeutics, Inc., Insulet Corporation, GlySens Incorporated, Johnson & Johnson, Medtronic plc, Senseonics Holdings, Inc., and F. Hoffmann-La Roche Ltd.

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com


For Media Inquiries, Please Contact

Shaun Godinho
Communications Officer
Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at


First time buyer?
Check offers and discount on this report
To get this report

Click Here

quote Continuous Glucose Monitoring Systems Market by Components (Sensors, Transmitters & Receivers, and Integrated Insulin Pumps), Demographics (Child Population (<=14years), and Adult Population (>14years), and End User (Clinics and Diagnostics Centers, ICUs, and Home Healthcare) - Global Opportunity Analysis and Industry Forecast, 2016-2024 quote

View Report

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time of readers


Featured Readings


Get Fresh content delivered

Get insights on topics that matter to your business. Stay updated on the area that interests you.

Get Industry Data Alerts

Buy Full Version
"Continuous Glucose Monitoring Systems (CGMS) Market"
Purchase Enquiry